Ethos Technologies Inc operates a technology-driven, direct-to-consumer platform for the distribution of life insurance products... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CPNX | 11.47 | N/A | N/A |
| Tradr 2X Long CPNG Daily ETF (CPNX) | |||
| VEGA | 52.10 | -0.49 | -0.94% |
| AdvisorShares STAR Global Buy-Write ETF (VEGA) | |||
| FJUL | 61.01 | -0.71 | -1.15% |
| FT Vest U.S. Equity Buffer ETF - July (FJUL) | |||
| NUMG | 44.78 | -1.51 | -3.26% |
| Nuveen ESG Mid-Cap Growth ETF (NUMG) | |||
| CBTJ | 19.36 | -0.76 | -3.77% |
| Calamos Bitcoin 80 Series Structured Alt Protection ETF - January (CBTJ) | |||
A.I.dvisor indicates that over the last year, LIFE has been loosely correlated with MDGL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if LIFE jumps, then MDGL could also see price increases.
| Ticker / NAME | Correlation To LIFE | 1D Price Change % | ||
|---|---|---|---|---|
| LIFE | 100% | -0.53% | ||
| MDGL - LIFE | 34% Loosely correlated | -0.31% | ||
| SER - LIFE | 34% Loosely correlated | +2.65% | ||
| TNYA - LIFE | 33% Poorly correlated | -7.78% | ||
| NTLA - LIFE | 32% Poorly correlated | -5.74% | ||
| AXON - LIFE | 32% Poorly correlated | -2.35% | ||
More | ||||
a developer of protein therapeutics and novel class of biologic drugs
Industry InsuranceBrokersServices
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where LIFE declined for three days, in 182 of 214 cases, the price declined further within the following month. The odds of a continued downward trend are 85%.
The 10-day RSI Indicator for LIFE moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In 19 of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
LIFE broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on LIFE as a result. In 38 of 50 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
The Moving Average Convergence Divergence (MACD) for LIFE just turned positive on October 12, 2026. Looking at past instances where LIFE's MACD turned positive, the stock continued to rise in 18 of 22 cases over the following month. The odds of a continued upward trend are 82%.
LIFE moved above its 50-day moving average on October 02, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for LIFE crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 78%.
Following a +2.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where LIFE advanced for three days, in 132 of 170 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 84 of 98 cases where LIFE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.
The Tickeron Profit vs. Risk Rating rating for this company is 13 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. LIFE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.707) is normal, around the industry mean (2.659). LIFE has a moderately low P/E Ratio (-25.534) as compared to the industry average of (18.304). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.322). Dividend Yield (0.000) settles around the average of (0.045) among similar stocks. P/S Ratio (4.186) is also within normal values, averaging (2.968).
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.